Distinct Genetic Loci Control Plasma HIV-RNA and Cellular HIV-DNA Levels in HIV-1 Infection: The ANRS Genome Wide Association 01 Study

Previous studies of the HIV-1 disease have shown that HLA and Chemokine receptor genetic variants influence disease progression and early viral load. We performed a Genome Wide Association study in a cohort of 605 HIV-1-infected seroconverters for detection of novel genetic factors that influence plasma HIV-RNA and cellular HIV-DNA levels. Most of the SNPs strongly associated with HIV-RNA levels were localised in the 6p21 major histocompatibility complex (MHC) region and were in the vicinity of class I and III genes. Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term HIV controllers. Furthermore, we show that the HIV-DNA levels (reflecting the HIV reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene). Our data provide evidence that the MHC controls both HIV replication and HIV reservoir. They also indicate that two additional genomic loci may influence the HIV reservoir.

[1]  K. Jeang,et al.  Role of RNA helicases in HIV-1 replication , 2006, Nucleic acids research.

[2]  C. Rouzioux,et al.  Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection , 2000, AIDS.

[3]  J. Reveille,et al.  Molecular basis of complete C4 deficiency in a SLE patient with four mutant genes: A 2- BP insertion at exon 29 in C4A and A 1-BP deletion at exon 13 in C4B , 2000 .

[4]  J. Esko,et al.  Contribution of Proteoglycans to Human Immunodeficiency Virus Type 1 Brain Invasion , 2004, Journal of Virology.

[5]  D. Boos On Generalized Score Tests , 1992 .

[6]  J. Wojcik,et al.  A Fast, Unbiased and Exact Allelic Test for Case-Control Association Studies , 2006, Human Heredity.

[7]  H. Ullum,et al.  Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. , 2001, Annals of internal medicine.

[8]  J. Lieberman,et al.  Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen , 2007, Science.

[9]  S. Riddell,et al.  Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. , 2001, Nature immunology.

[10]  D. Clayton,et al.  An R Package for Analysis of Whole-Genome Association Studies , 2007, Human Heredity.

[11]  J. Goedert,et al.  AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis , 2005, Nature Medicine.

[12]  F. Ramos-Morales,et al.  hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG , 1998, Oncogene.

[13]  J. Reveille,et al.  The Molecular Basis of Complete Complement C4A and C4B Deficiencies in a Systemic Lupus Erythematosus Patient with Homozygous C4A and C4B Mutant Genes1 , 2002, The Journal of Immunology.

[14]  J. Goedert,et al.  Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection , 1996, Nature Medicine.

[15]  E. Bruford,et al.  Mammalian SP/KLF transcription factors: bring in the family. , 2005, Genomics.

[16]  Scott F. Saccone,et al.  A Genome-Wide Association Study of Psoriasis and Psoriatic Arthritis Identifies New Disease Loci , 2008, PLoS genetics.

[17]  Yi Xie,et al.  Identification of a novel human DDX40 gene, a new member of the DEAH-box protein family , 2002, Journal of Human Genetics.

[18]  J. Goedert,et al.  Quantitation of Human Immunodeficiency Virus Type 1 DNA Forms with the Second Template Switch in Peripheral Blood Cells Predicts Disease Progression Independently of Plasma RNA Load , 2002, Journal of Virology.

[19]  John W. Mellors,et al.  Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.

[20]  P. Gallay,et al.  Syndecan captures, protects, and transmits HIV to T lymphocytes. , 2003, Immunity.

[21]  M. Crossley,et al.  Basic Krüppel-like factor functions within a network of interacting haematopoietic transcription factors. , 1999, The international journal of biochemistry & cell biology.

[22]  J. Church Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen , 2008, Pediatrics.

[23]  C. Rouzioux,et al.  Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy , 2001, AIDS.

[24]  L. Zon,et al.  The gene encoding TBC1D1 with homology to the tre-2/USP6 oncogene, BUB2, and cdc16 maps to mouse chromosome 5 and human chromosome 4 , 2000, Cytogenetic and Genome Research.

[25]  P. Morlat,et al.  CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  S. Melmed,et al.  An intronless homolog of human proto-oncogene hPTTG is expressed in pituitary tumors: evidence for hPTTG family. , 1999, The Journal of clinical endocrinology and metabolism.

[27]  J. Goedert,et al.  HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. , 1999, Science.

[28]  Tao Dong,et al.  Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57 , 2002, AIDS.

[29]  K. Roeder,et al.  Genomic Control for Association Studies , 1999, Biometrics.

[30]  Eric E. Schadt,et al.  Calibrating the Performance of SNP Arrays for Whole-Genome Association Studies , 2008, PLoS genetics.

[31]  C. Rouzioux,et al.  Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. , 2005, The Journal of infectious diseases.

[32]  L. Laloux,et al.  Allelic repertoire of the humanMHC class IMICA gene , 2007, Immunogenetics.

[33]  H. Ullum,et al.  Effects of CCR5- 32, CCR2-64I, and SDF-1 3A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data , 2001, Annals of Internal Medicine.

[34]  Jacques Fellay,et al.  A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 , 2007, Science.

[35]  B. Autran,et al.  Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. , 1999, Blood.

[36]  Amalio Telenti,et al.  Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1 , 2007, Nature Genetics.

[37]  F. Hecht,et al.  The Relation Between Symptoms, Viral Load, and Viral Load Set Point in Primary HIV Infection , 2007, Journal of acquired immune deficiency syndromes.

[38]  Thierry Moreau,et al.  A simple procedure for estimating the false discovery rate , 2005, Bioinform..

[39]  C. Rouzioux,et al.  Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level , 2003, AIDS.

[40]  Todd M. Allen,et al.  Structural and Functional Constraints Limit Options for Cytotoxic T-Lymphocyte Escape in the Immunodominant HLA-B27-Restricted Epitope in Human Immunodeficiency Virus Type 1 Capsid , 2008, Journal of Virology.

[41]  R. Lempicki,et al.  Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[43]  J. Wehland,et al.  IrpA , is highly homologous to monocytogenesPrfA-regulated gene in Listeria Identification and characterization of a novel , 1996 .

[44]  Laurence Meyer,et al.  Does transient HAART during primary HIV-1 infection lower the virological set-point? , 2004, AIDS.

[45]  S. Minoshima,et al.  Identification and characterization of a novel gene family YPEL in a wide spectrum of eukaryotic species. , 2004, Gene.

[46]  L. Laloux,et al.  Allelic repertoire of the human MHC class I MICA gene. , 1996, Immunogenetics.

[47]  A Steinle,et al.  Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.

[48]  J. Schalkwijk,et al.  Tenascin‐X, collagen, elastin, and the Ehlers–Danlos syndrome , 2005, American journal of medical genetics. Part C, Seminars in medical genetics.

[49]  J. Mellors,et al.  Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. , 1991, The Journal of infectious diseases.

[50]  Asier Sáez-Cirión,et al.  HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype , 2007, Proceedings of the National Academy of Sciences.

[51]  L. Laloux,et al.  Allelic repertoire of the human MICB gene , 1997, Immunogenetics.

[52]  Pardis C Sabeti,et al.  A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC , 2006, Nature Genetics.

[53]  C. Rouzioux,et al.  HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[54]  Radu V. Craiu,et al.  Stratified false discovery control for large‐scale hypothesis testing with application to genome‐wide association studies , 2006, Genetic epidemiology.